Conference Report of the 3rd Swiss Symposium in Point-of-Care Diagnostics held online on 29 October 2020

biotechnet Switzerland

Authors

  • Marc E. Pfeifer Institute of Life Technologies, School of Engineering, University of Applied Sciences and Arts Western Switzerland, Route du Rawil 47, Postfach 2134, CH-1950 Sitten 2
  • Dieter Ulrich CSEM Landquart SA, Bahnhofstr. 1, CH-7302 Landquart

DOI:

https://doi.org/10.2533/chimia.2021.219

Keywords:

Blockchain, Covid-19, Crispr/cas, Exhalomics, Lockdown, Patient empowerment, Preeclampsia, Sarscov-2, Sherlock, Telehealth, Poc cell counts

Abstract

The COVID-19 pandemic has raised in 2020 an unprecedented need for diagnostic testing, especially rapid testing, for SARS-CoV-2 infections. POC diagnostic tools, however, have clearly also importance in other domains such as oncology and women's health, because of the efficiency and convenience factors playing an increasingly important role in a mobile (and sometimes confined) and digitally connected world. Out of necessity, the 3rd edition of the Swiss Symposium in POC Diagnostics, originally planned to take place at the La Poste Conference Center in Visp, was smoothly run online with 170 engaged participants from science, industry and laboratory medicine.
CHIMIA Vol. 75 No. 3(2021): H₂ Production and CO₂ Conversion: Insights and Progress

Downloads

Published

2021-03-31

Issue

Vol. 75 No. 3 (2021): H₂ Production and CO₂ Conversion: Insights and Progress

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2021 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
M. E. Pfeifer, D. Ulrich, Chimia 2021, 75, 219, DOI: 10.2533/chimia.2021.219.